Figure 2From: Endocannabinoid signalling in the blood of patients with schizophreniaExpression levels of CB1, CB2 and FAAH mRNAs in patients in acute phase of schizophrenic illness and following pharmacologically-induced remission of the symptoms. The expression levels were evaluated by RT-PCR as described in the methods. Lanes 1, 3, 5, 7, 9: patients n° 3, 6, 8, 5 and 7 (see Table 1), in acute phase; lanes 2, 4, 6, 8 and 10: patients n° 3, 6, 8, 5 and 7, in remission. Panel A, B, C and D are relative to PCR analysis for β2-microglobulin (house-keeping), CB1, CB2 and FAAH, respectively. The bands shown in the figure are from 20 (Panel A), 35 (Panel B), 30 (Panel C) and 30 (Panel D) PCR amplification cycles.Back to article page